Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases

MicroRNAs (miRNAs) are the smallest class of noncoding RNAs, which widely exist in animals and plants. They can inhibit translation or overexpression by combining with mRNA and participate in posttranscriptional regulation of genes, resulting in reduced expression of target proteins, affecting the d...

Full description

Saved in:
Bibliographic Details
Main Authors: Ya-Min Ma, Lan Zhao
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.1155/2023/8537296
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559625614917632
author Ya-Min Ma
Lan Zhao
author_facet Ya-Min Ma
Lan Zhao
author_sort Ya-Min Ma
collection DOAJ
description MicroRNAs (miRNAs) are the smallest class of noncoding RNAs, which widely exist in animals and plants. They can inhibit translation or overexpression by combining with mRNA and participate in posttranscriptional regulation of genes, resulting in reduced expression of target proteins, affecting the development, growth, aging, metabolism, and other physiological and pathological processes of animals and plants. It is a powerful negative regulator of gene expression. It mediates the information exchange between different cellular pathways in cellular homeostasis and stress response and regulates the differentiation, plasticity, and neurotransmission of neurons. In neurodegenerative diseases, in addition to the complex interactions between genetic susceptibility and environmental factors, miRNAs can serve as a promising diagnostic tool for diseases. They can also increase or reduce neuronal damage by regulating the body’s signaling pathways, immune system, stem cells, gut microbiota, etc. They can not only affect the occurrence of diseases and exacerbate disease progression but also promote neuronal repair and reduce apoptosis, to prevent and slow down the development of diseases. This article reviews the research progress of miRNAs on the mechanism and treatment of neurodegenerative diseases in the nervous system. This trial is registered with NCT01819545, NCT02129452, NCT04120493, NCT04840823, NCT02253732, NCT02045056, NCT03388242, NCT01992029, NCT04961450, NCT03088839, NCT04137926, NCT02283073, NCT04509271, NCT02859428, and NCT05243017.
format Article
id doaj-art-62f913ff4aa44421aaee4913fcc7d346
institution Kabale University
issn 1875-8584
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Behavioural Neurology
spelling doaj-art-62f913ff4aa44421aaee4913fcc7d3462025-02-03T01:29:34ZengWileyBehavioural Neurology1875-85842023-01-01202310.1155/2023/8537296Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative DiseasesYa-Min Ma0Lan Zhao1Acupuncture and Massage Department of Nanyang Traditional Chinese Medicine HospitalTianjin Key Laboratory of Acupuncture and MoxibustionMicroRNAs (miRNAs) are the smallest class of noncoding RNAs, which widely exist in animals and plants. They can inhibit translation or overexpression by combining with mRNA and participate in posttranscriptional regulation of genes, resulting in reduced expression of target proteins, affecting the development, growth, aging, metabolism, and other physiological and pathological processes of animals and plants. It is a powerful negative regulator of gene expression. It mediates the information exchange between different cellular pathways in cellular homeostasis and stress response and regulates the differentiation, plasticity, and neurotransmission of neurons. In neurodegenerative diseases, in addition to the complex interactions between genetic susceptibility and environmental factors, miRNAs can serve as a promising diagnostic tool for diseases. They can also increase or reduce neuronal damage by regulating the body’s signaling pathways, immune system, stem cells, gut microbiota, etc. They can not only affect the occurrence of diseases and exacerbate disease progression but also promote neuronal repair and reduce apoptosis, to prevent and slow down the development of diseases. This article reviews the research progress of miRNAs on the mechanism and treatment of neurodegenerative diseases in the nervous system. This trial is registered with NCT01819545, NCT02129452, NCT04120493, NCT04840823, NCT02253732, NCT02045056, NCT03388242, NCT01992029, NCT04961450, NCT03088839, NCT04137926, NCT02283073, NCT04509271, NCT02859428, and NCT05243017.http://dx.doi.org/10.1155/2023/8537296
spellingShingle Ya-Min Ma
Lan Zhao
Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
Behavioural Neurology
title Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
title_full Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
title_fullStr Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
title_full_unstemmed Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
title_short Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
title_sort mechanism and therapeutic prospect of mirnas in neurodegenerative diseases
url http://dx.doi.org/10.1155/2023/8537296
work_keys_str_mv AT yaminma mechanismandtherapeuticprospectofmirnasinneurodegenerativediseases
AT lanzhao mechanismandtherapeuticprospectofmirnasinneurodegenerativediseases